Combivent Uses
Links shared publicly online about this topic
Combivent Respimat Inhalation Spray Approved for COPD - MPR
empr.com — “Boehringer Ingelheim announced that the FDA has approved Combivent Respimat (ipratropium bromide and albuterol), a propellant-free metered dose inhalation spray that uses a slow-moving mist, for the treatment of chronic obstructive pulmonary disease (COPD).” View full resource at empr.com
Most Recently Shared on October 10, 2011 at 3:15 pm By:
Combivent Respimat Inhalation Spray Approved for #COPD http://ow.ly/6SDtO
FDA Approves Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
drugs.com — “Combivent Respimat (albuterol and ipratropium bromide) is used to treat chronic obstructive pulmonary disease. Includes Combivent Respimat side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 11, 2011 at 12:07 am By:
FDA Approves Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray for COPD - http://t.co/3UJWkUpF
FDA Approves Combivent® Respimat® (ipratropium Bromide And Albuterol) Inhalation Spray For The Treatment Of Patients With COPD
medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-movin” View full resource at medicalnewstoday.com
Most Recently Shared on October 8, 2011 at 8:15 am By:
MedicalNewsToday: FDA Approves Combivent® Respimat® (ipratropium Bromide And Albuterol): http://t.co/ge6Qqfb1 Full http://t.co/Df7AzTG5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Asthma News
Track asthma blogs, new research, and other news on asthma. Go to the link above for daily emails. Contact:http://bit.ly/ktoIP
Advertisement
